Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activation

  • Boto, Carlos
  • Quartin, Emanuel
  • Cai, Yijun
  • Martín-Lorenzo, Alberto
  • García-Cenador, Begoña
  • Pinto, Sandra
  • Gupta, Rajeev
  • Enver, Tariq
  • Sánchez García, Isidro
  • Hong, Dengli
  • Pires das Neves, Ricardo
  • Ferreira, Lino
Leukaemia cells that are resistant to conventional therapies are thought to reside in protective niches. Here, we describe light-inducible polymeric retinoic acid (RA)-containing nano-particles (NPs) with the capacity to accumulate in the cytoplasm of leukaemia cells for several days and release their RA payloads within a few minutes upon exposure to blue/UV light. Compared to NPs that are not activated by light exposure, these NPs more efficiently reduce the clonogenicity of bone marrow cancer cells from patients with acute myeloid leukaemia (AML) and induce the differentiation of RA-low sensitive leukaemia cells. Importantly, we show that leukaemia cells transfected with light-inducible NPs containing RA can engraft into bone marrow in vivo in the proximity of other leukaemic cells, differentiate upon exposure to blue light and release paracrine factors that modulate nearby cells. The NPs described here offer a promising strategy for controlling distant cell populations and remotely modulating leukaemic niches., The authors would like to thank the financial support of FEDER through the programme COMPETE and by Portuguese funds through FCT (PTDC/CTM-NAN/120552/2010 and UID/NEU/04539/2013 to R.P.N.), FCT (SFRH/BD/62419/2009 to C.B.; SFRH/BD/90964/2012 to E.Q.; POCI-01-0145-FEDER-016390:CANCEL STEM to L.F.), EC (ERC project n° 307384, ‘Nanotrigger’ to L.F.), MINECO (SAF2012-32810, SAF2015-64420-R and Red de Excelencia Consolider OncoBIO SAF2014-57791-REDC to I.S.-G.) and Bloodwise and CRUK programme grants to T.E., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Antimicrobial peptide-gold nanoscale therapeutic formulation with high skin regenerative potential

  • Comune, Michela
  • Rai, Akhilesh
  • Chereddy, Kiran K.
  • Pinto, Sandra
  • Aday, Sezin
  • Ferreira, André F.
  • Zonari, Alessandra
  • Blersch, Josephine
  • Cunha, Rodrigo A.
  • Rodrigues, Ricardo J.
  • Lerma Gómez, Juan
  • Simões, Pedro N.
  • Préat, Veronique
  • Ferreira, Lino
Chronic skin wounds affect ≈ 3% of persons aged > 60 years (Davies et al., 2007) [1]. These wounds are typically difficult to heal by conventional therapies and in many cases they get infected making even harder the regeneration process. The antimicrobial peptide (AMP) LL37 combines antimicrobial with pro-regenerative properties and thus represents a promising topical therapy to address both problems. Here, we investigated the wound healing potential of soluble and immobilized LL37 (LL37-conjugated gold nanoparticles, LL37-Au NPs), both in vitro (migration of keratinocytes) and in vivo (skin wound healing). Our results show that LL37-Au NPs, but not LL37 peptide, have the capacity to prolong the phosphorylation of EGFR and ERK1/2 and enhance the migratory properties of keratinocytes in a large in vitro wound model. We further report that both LL37 and LL37-Au NPs promote keratinocyte migration by the transactivation of EGFR, a process that seems to be initiated at the P2X7 receptor, as confirmed by chemical and genetic inhibition studies. Finally, we show in vivo that LL37-Au NPs have higher wound healing activity than LL37 peptide in a splinted mouse full thickness excisional model. Animal wounds treated by LL37-Au NPs have higher expression of collagen, IL6 and VEGF than the ones treated with LL37 peptide or NPs without LL37. Altogether, the conjugation of AMPs to NPs offers a promising platform to enhance their pro-regenerative properties., The authors would like to thank the financial support of European Commission (ERC project n° 307384, “Nanotrigger”; Marie Curie ITN “NANODRUG”, FP7-PEOPLE-2011-ITN). The work was also funded by COMPETE in the context of the project “Stem cell based platforms for Regenerative and Therapeutic Medicine” (Centro-07-ST24-FEDER-002008)., Peer reviewed